Manufacturer record
Indica Pharmaceuticals (P) Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Indica Pharmaceuticals (P) Ltd (Gujarat) was declared Not of Standard Quality in September 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SD 243, Moxica -250 [Amoxicillin Dispersible Tablets IP 250 mg] (exp Jul 2025). DTL Thiruvananthapuram (state lab) found it not of standard quality: It fails the test ?Disintegration? and ?Uniformity of Dispersion? specified in the Laboratory Protocol as per IP. Listed in the September 2024 alert.
Records by type
1 record linked to Indica Pharmaceuticals (P) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Moxica -250 [Amoxicillin Dispersible Tablets IP 250 mg] | Batch SD 243Mfg Aug 2023 · Exp Jul 2025 | It fails the test ?Disintegration? and ?Uniformity of Dispersion? specified in the Laboratory Protocol as per IPDisintegration | DTL ThiruvananthapuramState lab | Sep 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.